Janux Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Janux Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Janux Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Janux Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $743k | 16k | 45.43 |
| 2024-06-30 | $685k | 16k | 41.89 |
| 2023-12-31 | $114k | 11k | 10.73 |
| 2023-09-30 | $107k | 11k | 10.08 |
| 2023-06-30 | $126k | 11k | 11.87 |
| 2023-03-31 | $128k | 11k | 12.10 |
| 2022-12-31 | $140k | 11k | 13.17 |
| 2022-09-30 | $144k | 11k | 13.54 |
| 2022-06-30 | $130k | 11k | 12.25 |
| 2022-03-31 | $152k | 11k | 14.34 |
| 2021-12-31 | $105k | 5.3k | 19.80 |
| 2021-09-30 | $115k | 5.3k | 21.63 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors